Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study-Reference-Cited by-同舟云学术

Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study

Published:2017-02-15 Issue:4 Volume:26 Page:481-487
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Espinoza-Zamora Jose Ramiro¹,Labardini-Méndez Juan¹,Sosa-Espinoza Alejandro¹,López-González Celia¹,Vieyra-García Magnolia¹,Candelaria Myrna²,Lozano-Zavaleta Valentin¹,Toledano-Cuevas Diana Vanesa¹,Zapata-Canto Nidia¹,Cervera Eduardo¹,Dueñas-González Alfonso³

Affiliation:

1. Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico

2. Division of Clinical Research, Instituto Nacional de Cancerología, Mexico City, Mexico

3. Unidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas UNAM/Instituto Nacional de Cancerología, Mexico City, Mexico

Funder

LABORATORIOS ALPHARMA, S.A. DE C.V.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1291630

Reference41 articles.

1. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

2. New drugs in cutaneous T-cell lymphomas

3. Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma

4. Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

5. Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches to anticancer therapy based on modulation of DNA methylation;Siberian journal of oncology;2024-09-09

2. The inhibitory and transcriptional effects of the epigenetic repurposed drugs hydralazine and valproate in lymphoma cells;American Journal of Cancer Research;2024

3. Patenting Trends by Mexican Pharmaceutical Companies;Pharmaceutical Patent Analyst;2023-11

4. Epigenetic Regulations in Autoimmunity and Cancer: from Basic Science to Translational Medicine;European Journal of Immunology;2023-02-23

5. Patenting trends in the pharmaceutical field of Mexican universities;Pharmaceutical Patent Analyst;2023-01